Anticancer Activity of the Safflower Seeds (Carthamus tinctorius L.) through Inducing Cyclin D1 Proteasomal Degradation in Human Colorectal Cancer Cells
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The seed of safflower (Carthamus tinctorius L) has been reported to suppress human cancer cell proliferation. However, the mechanisms by which safflower seed inhibits cancer cell proliferation have remained nuclear. In this study, the inhibitory effect of the safflower seed (SS) on the proliferation of human colorectal cancer cells and the potential mechanism of action were examined. SS inhibited markedly the proliferation of human colorectal cancer cells (HCT116, SW480, LoVo and HT-29). In addition, SS suppressed the proliferation of human breast cancer cells (MDA-MB-231 and MCF-7). SS treatment decreased cyclin D1 protein level in human colorectal cancer cells and breast cancer cells. But, SS-mediated downregulated mRNA level of cyclin D1 was not observed. Inhibition of proteasomal degradation by MG132 attenuated cyclin D1 downregulation by SS and the half-life of cyclin D1 was decreased in SS-treated cells. In addition, SS increased cyclin D1 phosphorylation at threonine-286 and a point mutation of threonine-286 to alanine attenuated SS-mediated cyclin D1 degradation. Inhibition of ERK1/2 by PD98059 suppressed cyclin D1 phosphorylation and downregulation of cyclin D1 by SS. In conclusion, SS has anti-proliferative activity by inducing cyclin D1 proteasomal degradation through ERK1/2-dependent threonine-286 phosphorylation of cyclin D1. These findings suggest that possibly its extract could be used for treating colorectal cancer. Key words - Safflower seed, Anticancer activity, Cyclin D1, Human colorectal cancer, Cancer chemoprevention
Abstract
The seed of safflower (Carthamus tinctorius L) has been reported to suppress human cancer cell proliferation. However, the mechanisms by which safflower seed inhibits cancer cell proliferation have remained nuclear. In this study, the inhibitory effect of the safflower seed (SS) on the proliferation of human colorectal cancer cells and the potential mechanism of action were examined. SS inhibited markedly the proliferation of human colorectal cancer cells (HCT116, SW480, LoVo and HT-29). In addition, SS suppressed the proliferation of human breast cancer cells (MDA-MB-231 and MCF-7). SS treatment decreased cyclin D1 protein level in human colorectal cancer cells and breast cancer cells. But, SS-mediated downregulated mRNA level of cyclin D1 was not observed. Inhibition of proteasomal degradation by MG132 attenuated cyclin D1 downregulation by SS and the half-life of cyclin D1 was decreased in SS-treated cells. In addition, SS increased cyclin D1 phosphorylation at threonine-286 and a point mutation of threonine-286 to alanine attenuated SS-mediated cyclin D1 degradation. Inhibition of ERK1/2 by PD98059 suppressed cyclin D1 phosphorylation and downregulation of cyclin D1 by SS. In conclusion, SS has anti-proliferative activity by inducing cyclin D1 proteasomal degradation through ERK1/2-dependent threonine-286 phosphorylation of cyclin D1. These findings suggest that possibly its extract could be used for treating colorectal cancer. Key words - Safflower seed, Anticancer activity, Cyclin D1, Human colorectal cancer, Cancer chemoprevention
참고문헌 (26)
- Alam, M. R., "Effects of Safflower seed oil in osteoporosis induced-ovariectomized rats", Am. J. Chin. Med, 34, pp.601~612 (2006)
- Alt, J. R., "Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation", Genes Dev, 14, pp.3102~3114 (2000)
- Bae, S. J., "Cytotoxicity of phenolic compounds isolated from seeds of safflower(Carthamus tinctorius L. )on cancer cells lines", Food Sci. Biotechnol, 11, pp.140~146 (2002)
- Bahnassy, A. A., "Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients", BMC Gastroenterol, 23, pp.22~24 (2004)
- Barbash, O., "SCF(Fbx4", alphaB-crystallin)E3 ligase : when one is not enough, 2008, pp.7, 2983~2986
- Benzeno, S., "Identification of mutations that disrupt phosphorylationdependent nuclear export of cyclin D1", Oncogene, 25, pp.6291~6303 (2006)
- Cha, Y. J., "Multidrug-resistance reversing activity of extracts from gamma-irradiated Carthanus tinctorius L. Seed", Korean J. Plant Res, 5, pp.118~120 (2004)
- Diehl, J. A., "Cycling to cancer with cyclin D1", Cancer Biol. Ther, 1, pp.226~231 (2002)
- Diehl, J. A., "Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization", Genes Dev, 12, pp.3499~3511 (1998)
- Holland, T. A., "Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1", CIP1)expression and correlates with patient survival, 2001, pp.95, 302~306
- Hong, H. T., "Inhibitory effect of a Korean traditional medicine, Honghwain-Jahage(water extracts of Carthamus tinctorius L. seed and Hominis placenta)on interleukin-1-mediated bone resorption", J. Ethnopharmacol, 79, pp.143~148 (2002)
- Kim, H. M., "Rehmannia Glutinosa inhibits tumor necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes", Pharmacol. Res, 40, pp.171~176 (1999)
- Kim, Y. K., "Inhibitory effects of deer antler aqua-acupuncture, the pilose antler of Cervus Korean TEMMINCK var mantchuricus Swinhoe, on type II collageninduced arthritis in rats", Int. Immunopharmacol, 3, pp.1001~1010 (2003)
- Kwak, Y. T., "IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation", J. Biol. Chem, 280, pp.33945~33952 (2005)
- Landis, M. W., "Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis", Cancer Cell, 9, pp.13~22 (2006)
- Lee, Y. M., "Targeting cyclins and cyclin-dependent kinases in cancer : lessons from mice, hopes for therapeutic applications in human", Cell Cycle, 5, pp.2110~2114 (2006)
- Li, Z., "Cyclin D1 functions in cell migration", Cell Cycle, 5, pp.2440~2442 (2006)
- Moon, K. D., "Safflower seed extract lowers plasma and hepatic lipids in rats fed high-cholesterol diet", Nutr. Res, 21, pp.895~904 (2001)
- Mori, H., "Cell proliferation in cancer prevention;effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells", Mutat. Res, 480-481, pp.201~207 (2001)
- Mori, H., "Control of cell proliferation in cancer prevention", Mutat. Res, 428, pp.291~298 (1999)
- Musgrove, E. A., "Cyclin D as a therapeutic target in cancer", Nat. Rev. Cancer, 11, pp.558~572 (2011)
- Okabe, H., "A critical role for FBXW8and MAPK in cyclin D1 degradation and cancer cell proliferation", PloS One, 1, pp.e128~ (2006)
- Rimerman, R. A., "Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation", J. Biol. Chem, 275, pp.14736~14742 (2000)
- Shan, J., "Suppression of cancer cell growth by promoting cyclin D1 degradation", Mol. Cell, 36, pp.469~476 (2009)
- Sherr, C. J., "Cancer cell cycles", Science, 274, pp.1672~1677 (1996)
- Takahashi-Yanaga, F., "GSK-3beta regulates cyclin D1 expression : a new target for chemotherapy", Cell. Signal, 20, pp.581~589 (2008)